Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.
about
Exogenous endophthalmitis in diabetic patients: a systemic reviewTreatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.Incidence and Determinants of Endophthalmitis within 6 Months of Surgeries over a 2-Year Period at King Khaled Eye Specialist Hospital, Saudi Arabia: A Review.Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Endophthalmitis: A review of recent trends.Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.Endophthalmitis following intravitreal injections.Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma.Experience of intravitreal injections in a tertiary Hospital in Oman.A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab.
P2860
Q26859314-1A2682E8-EFAF-4D21-9D0D-62354D95B2EEQ33968834-BF15EF22-34BE-4A7F-8C82-2794FF5709B5Q35544182-BF8C8EC9-C4F3-4E39-97EE-29F77B2F2B21Q35693314-8AF3600F-927A-4FE5-9745-1BEEEEE16A14Q36743069-4D78CD30-A3AF-44C4-B57F-23CF36DFDF21Q36762577-D1F141A1-7052-49EF-AC4A-5A4FC0312915Q37060506-CF7159A8-965F-477F-9837-E7DCD5766EE9Q37879167-F7CF13FB-1BBE-43DE-A3D2-1F1882B25A23Q37910660-585C000C-3F5F-4386-B64B-00F4DED0EFC4Q37952079-B176D5F2-84BC-4E22-AFB2-68518D49EF2FQ38149120-D65DC92D-0D9B-4583-B781-DE7A46D55D02Q38745804-8DCF972F-C82D-445B-9F6A-F5AF2ACB3424Q40625734-AD32DA1E-27B4-4F02-9068-A00008ADF216Q41578281-90B87738-1C0D-46AF-A87C-CCB4188BF5B8
P2860
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@en
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@nl
type
label
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@en
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@nl
prefLabel
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@en
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@nl
P2093
P2860
P356
P1476
Intravitreal injection analysi ...... ence rates of endophthalmitis.
@en
P2093
Amy C Schefler
Andrew A Moshfeghi
Christina L Decatur
Harry W Flynn
Kyle J Alliman
Lisa C Olmos
Ludimila L Cavalcante
Michael B Parrott
Michael M Vigoda
Milena L Cavalcante
P2860
P304
P356
10.2147/OPTH.S11094
P407
P577
2010-05-25T00:00:00Z